TRIFLUOROMETHANESULFONAMIDE 三氟甲磺酰胺 421-85-2 Triglycine 甘氨酰-甘氨酰-甘氨酸 556-33-2 Trimethyl[(1-methylene-2-propenyl)oxy]silane 2-三甲基硅氧基-1,3-丁二烯 38053-91-7 Tropinone 托品酮 532-24-1 Tubeimoside I 土贝母皂甙甲 102040-03-9 Tyramine 4-羟基苯乙胺 51-67-2 ...
1-Bromo-2-pentyne1-溴-2-戊炔16400-32-1 N-Methyl-N-(trimethylsilyl)acetamideN-甲基-N-(三甲基硅基)乙酰胺7449-74-3 Bis(trimethylsilyl)acetylene双三甲基硅乙炔14630-40-1 1-Chloro-N,N,2-trimethylpropenylamine1-氯-N,N,2-三甲基丙烯胺26189-59-3 ...
(+/-)-4-methyloxetan-2-one in chemges enthaltene rohstoffe seite 4 cas-nummer 99095-19-9 15932-80-6 109887-53-8 112281-77-3 107898-54-4 119738-06-6 105813-13-6 105813-13-6 489-40-7 7787-20-4 498-07-7 53531-34-3 37002-45-2 73346-74-4 552-79-4 14073-97-3 51865-79-...
(oxetan-3-yl)borate95%25mg7955个工作日0.001P848605-100mg1430219-76-33-氧杂环丁烷三氟硼酸钾Potassium trifluoro(oxetan-3-yl)borate95%100mg19075个工作日0.001P848609-50mg1000802-52-71-[2-(1-吡咯烷)乙基]-4-(4,4,5,5-四***-1,3,2-二噁***-2-基)-1H-吡唑1-(2-(Pyrrolidin-1-yl)...
2-Chloro-1-(1,2-dimethyl-1H-indol-3-yl)-2,2-difluoroethan-1-one 2-Chloro-1-(1,2-dimethyl-1H-indol-3-yl)-2,2-difluoroethan-1-one 分子量:257.66密度:N/A 沸点:N/A熔点:N/A 1620097-93-9 C12H10ClF2NO 1-(2-Bromo-1-(2-methoxyethoxy)ethyl)-2-methylbenzene 1-(2-Bromo-1-...
oxetan-3-ylidene-acetaldehydecas:922500-93-4 2H-Indol-2-one, 5,6-dichloro-3-[1,3-dihydro-3-(methoxyimino)-2H-indol-2-ylidene]-1,3-dihydro-cas:2226664-93-1 1,3-Bis(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-2-propanonecas:24293-93-4 Acetaldehyde, (3,4-dihydro-6-methyl...
(oxetan-3-yl)borate95%25mg7955个工作日0.001P848605-100mg1430219-76-33-氧杂环丁烷三氟硼酸钾Potassium trifluoro(oxetan-3-yl)borate95%100mg19075个工作日0.001P848609-50mg1000802-52-71-[2-(1-吡咯烷)乙基]-4-(4,4,5,5-四***-1,3,2-二噁***-2-基)-1H-吡唑1-(2-(Pyrrolidin-1-yl)...
Oxetan-3-olC3H6O27748-36-9Details 1,1-Dimethylethyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylateC11H19NO31147557-97-8Details 2-Chloro-4-fluorobenzoic acidC7H4ClFO22252-51-9Details 2-Methoxy-3-methylbenzoic acidC9H10O326507-91-5Details ...
There is provided medicaments, particularly a vascular endothelial growth factor (VEGF) inhibitor which is useful as a therapeutic drug for solid tumors, diabetic retinopathy and th
N and S, wherein the 4 to 6-membered heterocycloalkyl is optionally substituted with 1 to 3 substituents independently selected from halo, C1-4alkyl and C1-4haloalkyl; and m is 1 or 2, provided that the compound is not any one of the following, or a pharmaceutically acceptable salt the...